Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: A role for the nicotinic receptor

Journal of Neuroscience Research

Volumn 87, Issue 1, 2009, Pages 200-207

  Di Cesare Mannelli, Lorenzo ^a   Ghelardini, Carla ^a   Calvani, Menotti ^b   Nicolai, Raffaella ^b   Mosconi, Luigi ^b   Toscano, Annarita ^a   Pacini, Alassandra ^a   Bartolini, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Sigma Tau SpA   (Italy)

Author keywords

Atropine; Caspase 3; CCI; Mecamylamine; XIAP

Indexed keywords

ATROPINE; LEVACECARNINE; MECAMYLAMINE; NICOTINIC RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; HYPERALGESIA; MALE; NERVE LIGATION; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PAIN THRESHOLD; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SCIATIC NERVE;

ACETYLCARNITINE; ANIMALS; APOPTOSIS; ATROPINE; CASPASE 3; CYTOCHROMES C; DISEASE MODELS, ANIMAL; IN SITU NICK-END LABELING; MALE; MECAMYLAMINE; MUSCARINIC ANTAGONISTS; NEUROPROTECTIVE AGENTS; NICOTINIC ANTAGONISTS; PAIN MEASUREMENT; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SCIATICA; TIME FACTORS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 63049089317     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21815     Document Type: Article

References (39)

1. Andrews PLR, Friedman AI, Liu Y, Smith JE, Sims DW. 2005. Potential energetic implications of emesis in the house musk shrew (Suncus murinus). Physiol Behav, 84:519-524.
2. Bannon AW, Decker MW, Holladay MW, Curzon P, Donnelly-Roberts D, Puttfarcken PS, Bitner RS, Diaz A, Dickenson AH, Porsolt RD, Williams M, Americ SP. 1998. Broad spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 279:77-81.
3. Bennett GJ, Xie YK. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
4. Bigini P, Larini S, Pasquali C, Muzio V, Mennini T. 2002. Acetyl-L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons. Neurosci Lett 329:334-338.
5. Bremer J. 1990. The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem 28:297-301.
6. Budd SL, Nicholls DG. 1998. Mitochondria in the life and death of neurons. Essays Biochem 33:43-52.
7. Bunnelle WH, Daanen JF, Rythet KB, Schrimpf MR, Dart MJ, Gelain A, Meyer MD, Frost JM, Anderson DJ, Buckley M, Curzon P, Cao YJ, Puttfarcken P, Searle X, Ji J, Putman CB, Surowy C, Toma L, Barlocco D. 2007. Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors. J Med Chem 50:3627-3644.
8. Cervia D, Martini D, Garcia-Gil M, Di Giuseppe G, Guella G, Dini F, Bagnoli P. 2006. Cytotoxic effects and apoptotic signalling mechanisms of the sesquiterpenoid euplotin C, a secondary metabolite of the marine ciliate Euplotes crassus, in tumour cells. Apoptosis 115:829-843.
9. Chiechio S, Caricasole A, Barletta E, Storto M, Catania MV, Copani A, Vertechy M, Nicolai R, Calvani M, Melchiorri D, Nicoletti F. 2002. L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. Mol Pharmacol 61:989-996.
10. Copeland RL Jr, Das JR, Kanaan YM, Taylor RE, Tizabi Y. 2007. Anti-apoptotic effects of nicotine in its protection, against salsolinol-induced cytotoxicity. Neurotox Res 12:61-69.
11. Dasgupta P, Kinkade R, Joshi B, DeCook C, Haura E, Chellappan S. 2006. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and surviving. Proc Natl Acad Sci U S A 103:6332-6337.
12. Davis L, Pollock LJ, Stone TT. 1932. Visceral pain. Surg Gynecol Obstet 55:418-427.
13. Di Cesare Mannelli L, Ghelardini C, Calvani Nicolai R, Mosconi L, Vivoli E, Pacini A, Bartolini A. 2007. Protective effect of acetyl-l-carnitine on the apoptotic pathway of peripheral neuropathy. Eur J Neurosci 26:820-827.
14. Fernandez E, Pallini PR, Gangitario C, Aurora DF, Sangiacomo CO, Sbricioli A, Ricoy J, Rossi GF. 1989. Effects of L-carnitine, L-acetylcarnitine and gangliosides; on the regeneration of the transected sciatic nerve in rats. Neurol Res 11:57-62.
15. Galeotti N, Bartolini A, Calvani M, Nicolai R, Ghelardini C. 2004. Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. Neuropharmacology 472:286-294.
16. Ghelardini C, Galeotti N, Calvani M, Mosconi L, Nicolai R, Bartolini A. 2002. Acetyl-L-carnitine induces muscarinic antinocieption in mice and rats. Neuropharmacology 43:1180-1187.
17. Hart AM, Wiberg M, Youle M, Terenghi G. 2002. Systemic acetyl-L-carnitine eliminates sensory neuronal loss after pezipheral axotomy: a new clinical approach in the management of peripheral nerve trauma. Exp Brain-Res 145:182-189.
18. Imperato A, Ramacci MT, Angelucci L. 1989. Acetyl-L-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats. Neurosci Lett 107:251-255.
19. Jensen TS, Gottrup H, Sindrup SH, Bach FW. 2001. The clinical picture of neuropathic pain. Eur J Pharmacol 429:1-11.
20. Ji J, Bunnelle WH, Anderson DJ, Faltynek C, Dyhring T, Ahring PK, Rueter LE, Curzon P, Buckley MJ, Marsh KC, Kempf-Grote A, Meyer MD. 2007. A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: synthesis, analgesic efficacy and tolerability profile in animal models. Biochem Pharmacol 74:1253-1262.
21. Joseph EK, Levine JD. 2004. Caspase signaling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 20:2896-2902.
22. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, Kume T, Akaike A. 2001. Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276:13541-13546.
23. Kihara T, Shimohama S, Urushitani M, Sawada H, Kimura J, Kume T, Maeda T, Akaike A. 1998. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res 792:331-334.
24. Leighton GE, Rodriguez RE, Hill RG, Hughes J. 1988. k-Opioid-agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br J Pharmacol 93:553-560.
25. Liu Q, Zhao B. 2004. Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. Br J Pharmacol 141:746-754.
26. Manfridi A, Forloni GL, Arrigoni-Martelli E, Mancia M. 1992. Culture of dorsal root ganglion neurons from aged rats: effects of acetyl-L-carnitine and NGF. Int J Dev Neurosci 10:321-329.
27. Mansour HH. 2006. Protective role of carnitine ester against radiation-induced oxidative stress in rats. Pharmacol Res 54:165-171.
28. McKay-Hart A, Wiberg M, Terenghi G. 2002. Pharmacological enhancement of peripheral nerve regeneration in the rat by systemic acetyl-L-carnitine treatment. Neurosci Lett 334:181-185.
29. Ori C, Freo U, Pizzolato, G, Dam M. 2002. Effects of acetyl-L-carnitine on regional cerebral glucose metabolism in awake rats. Brain Res 951:330-335.
30. Osio M, Muscia F, Zampini L, Nascimbene C, Mailland E, Cargnel A, Mariani C. 2006. AcetyL-L-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study. J Peripher Nerv Syst 11:72-76.
31. Pettegrew JW, Levine J, McClure RJ. 2000. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol Psychiatry 5:616-632.
32. Pisano C, Pratesi G, Laccabue D, Zumino, F, Lo Giudice P, Bellocci A, Pacifici L, Camerini B, Vesci L, Castorina M, Cocuzza S, Tredici G, Marmiroli P, Nicolini G, Galbiati S, Calvani M, Carminati P, Cavaletti G. 2003. Paclitaxel and cisplatin-induced neurotoxicity. A protective role of acetyl-L-carnitine. Clin Cancer Res 9:5756-5767.
33. Rapoport SI. 1999. In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling. Neurochem Res 24:1403-1415.
34. Rosa AO, Egea J, Gandia L, Lopez MG, Garcia AG. 2006. Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype. J Mol Neurosci 30:61-62.
35. Takaishi K, Eisele JH Jr, Carstens E. 1996. Behavioral and electrophysiological assessment of hyperalgesia and changes in dorsal-horn responses following partial sciatic nerve ligatioii in rats. Pain 66:297-306.
36. Tempesta E, Janiri L, Pirrongelli C. 1985. Stereospecific effects of acetyl-carnitine on the spontaneous activity of brainstem neurcones and their responses to acetylcholine and serotonin. Neuropharmacology 24:43-50.
37. Tesco G, Latorraca S, Piersanti P, Piacentini S, Amaducci L, Sorbi S. 1992. Protection from oxygen radio: damage in human diploid fibroblasts by acetyl-L-carnitine. Dementia 3:58-64.
38. Virmani MA, Biselli R, Spadoni A, Rossi S, Corsico N, Calvani M, Fattorissi A, De Simone C, Arrigoni-Martelli E. 1995. Protective actions of L-Carnitine and acetyl-L-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors. Pharmacol Res 32:383-389.
39. White HL, Scates PW. 1990. Acetyl-L-carnitine as precursor of acerylcholine. Neurochem Res 15:597-601.